Cellebrite Enhances Guardian with Faster, First-to-Market Evidence Review Capabilities

Go back to Cellebrite Enhances Guardian with Faster, First-to-Market Evidence Review Capabilities
(NASDAQ: CLBT) Delayed: 11.85 -0.15 (1.25%)
Previous Close $12.00    52 Week High
Open $11.88    52 Week Low
Day High $11.98    P/E N/A 
Day Low $11.82    EPS
Volume 933,885       

(NASDAQ: CLBT) Delayed: 11.85 -0.15 (1.25%)
Previous Close $12.00    52 Week High
Open $11.88    52 Week Low
Day High $11.98    P/E N/A 
Day Low $11.82    EPS
Volume 933,885